Types of Insulin
Insulin is available in rapid-acting, short-acting, intermediate-acting, and long-acting types that can be injected separately or mixed in the same syringe to provide optimal glycemic control for patients with diabetes. 1
Classification of Insulin Types
Rapid-Acting Insulins
- Examples: Insulin lispro, insulin aspart, insulin glulisine 1, 2
- Onset: 15-30 minutes
- Peak Action: 1-3 hours
- Duration: 3-5 hours
- Appearance: Clear solution 1
- Clinical Use: Administered immediately before meals to control postprandial glucose excursions 2
Short-Acting Insulins
- Example: Regular insulin (Humulin R) 1
- Onset: 30-60 minutes
- Peak Action: 2-4 hours
- Duration: 5-8 hours
- Appearance: Clear solution 1
- Clinical Use: Administered 30 minutes before meals
Intermediate-Acting Insulins
- Examples: NPH (Neutral Protamine Hagedorn), Lente 1
- Onset: 2-4 hours
- Peak Action: 4-12 hours
- Duration: 12-18 hours
- Appearance: Uniformly cloudy suspension 1
- Clinical Use: Provides basal insulin coverage
Long-Acting Insulins
- Examples: Insulin glargine, insulin detemir, insulin degludec 1, 2
- Onset: 1-2 hours
- Peak Action: Minimal peak (relatively flat profile)
- Duration: 20-24+ hours
- Appearance: Clear solution (glargine) 1
- Clinical Use: Provides steady background insulin coverage with less risk of nocturnal hypoglycemia 2
Premixed Insulin Formulations
Premixed insulins combine fixed ratios of intermediate-acting insulin with short or rapid-acting insulin:
- 70% NPH/30% regular
- 50% NPH/50% regular
- 75% NPL/25% insulin lispro 1
These formulations offer convenience for patients who have difficulty mixing insulins or who need simplified regimens.
Source and Manufacturing
Modern insulins are produced through several methods:
- Recombinant DNA technology: Most common method for human insulin production using bacteria or yeast 1
- Animal-derived: Historically obtained from pork pancreas, less commonly used today 1
- Insulin analogs: Created by modifying the amino acid sequence of the insulin molecule to alter pharmacokinetic properties 1
Clinical Considerations
Storage Requirements
- Unopened insulin should be refrigerated (36-46°F/2-8°C) 3
- Insulin in use can be kept at room temperature (below 86°F/30°C) for limited periods:
- Most insulins: 28 days
- Insulin in pumps: 19 days 4
- Avoid freezing or exposure to extreme heat or direct sunlight 3
Visual Inspection
- Rapid-acting and short-acting insulins should appear clear
- Intermediate and premixed insulins should appear uniformly cloudy
- Inspect for clumping, frosting, precipitation, or color changes before use 1
Mixing Guidelines
- Insulin glargine should not be mixed with other insulins due to its acidic pH 1
- NPH can be mixed with rapid or short-acting insulins 1
- Phosphate-buffered insulins (e.g., NPH) should not be mixed with lente insulins 1
Modern Insulin Therapy Approaches
Basal-Bolus Therapy
This approach most closely mimics physiological insulin secretion:
- Basal component: Long-acting insulin provides background insulin coverage
- Bolus component: Rapid-acting insulin at mealtimes addresses postprandial glucose excursions 2, 5
Benefits of Newer Insulin Analogs
- Faster onset of action for rapid-acting analogs
- More predictable absorption
- Lower risk of hypoglycemia, especially nocturnal hypoglycemia
- Less day-to-day variability in glucose control 2, 6
Common Pitfalls and Caveats
Insulin substitution risks: Changes in insulin type, brand, or species should be made cautiously and only under medical supervision, as dosage adjustments may be required 3
Visual inspection importance: Always inspect insulin before use; cloudy insulins that appear clear or clear insulins that appear cloudy may indicate loss of potency 1
Mixing incompatibilities: Some insulins cannot be mixed (e.g., insulin glargine with other insulins) 1
Storage errors: Improper storage can lead to loss of potency; never use insulin that has been frozen or exposed to extreme heat 3
Confusing insulin types: Mistaking rapid-acting for long-acting insulin (or vice versa) can lead to dangerous dosing errors 2
By understanding the different types of insulin and their properties, healthcare providers can select appropriate insulin regimens that optimize glycemic control while minimizing the risk of hypoglycemia and other complications.